Letter: infliximab and adalimumab in the management of Crohn's disease--are they really comparable?
- PMID: 22860615
- DOI: 10.1111/j.1365-2036.2012.05185.x
Letter: infliximab and adalimumab in the management of Crohn's disease--are they really comparable?
Comment on
-
Efficacy and safety of infliximab and adalimumab in Crohn's disease: a single centre study.Aliment Pharmacol Ther. 2012 Jun;35(12):1397-407. doi: 10.1111/j.1365-2036.2012.05100.x. Epub 2012 Apr 22. Aliment Pharmacol Ther. 2012. PMID: 22519466
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical